-
Je něco špatně v tomto záznamu ?
NPFFR2-deficient mice fed a high-fat diet develop strong intolerance to glucose
A. Karnošová, V. Strnadová, B. Železná, J. Kuneš, P. Kašpárek, L. Maletínská
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
PubMed
37191311
DOI
10.1042/cs20220880
Knihovny.cz E-zdroje
- MeSH
- bílá tuková tkáň metabolismus MeSH
- dieta s vysokým obsahem tuků MeSH
- glukosa metabolismus MeSH
- inzulinová rezistence * MeSH
- játra metabolismus MeSH
- myši inbrední C57BL MeSH
- myši knockoutované MeSH
- myši MeSH
- obezita metabolismus MeSH
- porucha glukózové tolerance * metabolismus MeSH
- tuková tkáň metabolismus MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
A previous study on neuropeptide FF receptor 2 (NPFFR2)-deficient mice has demonstrated that NPFFR2 is involved in the control of energy balance and thermogenesis. Here, we report on the metabolic impact of NPFFR2 deficiency in male and female mice that were fed either a standard diet (STD) or a high-fat diet (HFD) and each experimental group consisted of ten individuals. Both male and female NPFFR2 knockout (KO) mice exhibited severe glucose intolerance that was exacerbated by a HFD diet. In addition, reduced insulin pathway signaling proteins in NPFFR2 KO mice fed a HFD resulted in the development of hypothalamic insulin resistance. HFD feeding did not cause liver steatosis in NPFFR2 KO mice of either sex, but NPFFR2 KO male mice fed a HFD had lower body weights, white adipose tissues, and liver and lower plasma leptin levels compared with their wild-type (WT) controls. Lower liver weight in NPFFR2 KO male mice compensated for HFD-induced metabolic stress by increased liver PPARα and plasma FGF21 hepatokine, which supported fatty acid β-oxidation in the liver and white adipose tissue. Conversely, NPFFR2 deletion in female mice attenuated the expression of Adra3β and Pparγ, which inhibited lipolysis in adipose tissue.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24001297
- 003
- CZ-PrNML
- 005
- 20240213094528.0
- 007
- ta
- 008
- 240109s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1042/CS20220880 $2 doi
- 035 __
- $a (PubMed)37191311
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Karnošová, Alena $u Biochemistry and molecular biology, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610 Prague, Czech Republic $u First Faculty of Medicine, Charles University, 12108 Prague, Czech Republic
- 245 10
- $a NPFFR2-deficient mice fed a high-fat diet develop strong intolerance to glucose / $c A. Karnošová, V. Strnadová, B. Železná, J. Kuneš, P. Kašpárek, L. Maletínská
- 520 9_
- $a A previous study on neuropeptide FF receptor 2 (NPFFR2)-deficient mice has demonstrated that NPFFR2 is involved in the control of energy balance and thermogenesis. Here, we report on the metabolic impact of NPFFR2 deficiency in male and female mice that were fed either a standard diet (STD) or a high-fat diet (HFD) and each experimental group consisted of ten individuals. Both male and female NPFFR2 knockout (KO) mice exhibited severe glucose intolerance that was exacerbated by a HFD diet. In addition, reduced insulin pathway signaling proteins in NPFFR2 KO mice fed a HFD resulted in the development of hypothalamic insulin resistance. HFD feeding did not cause liver steatosis in NPFFR2 KO mice of either sex, but NPFFR2 KO male mice fed a HFD had lower body weights, white adipose tissues, and liver and lower plasma leptin levels compared with their wild-type (WT) controls. Lower liver weight in NPFFR2 KO male mice compensated for HFD-induced metabolic stress by increased liver PPARα and plasma FGF21 hepatokine, which supported fatty acid β-oxidation in the liver and white adipose tissue. Conversely, NPFFR2 deletion in female mice attenuated the expression of Adra3β and Pparγ, which inhibited lipolysis in adipose tissue.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a tuková tkáň $x metabolismus $7 D000273
- 650 _2
- $a bílá tuková tkáň $x metabolismus $7 D052436
- 650 _2
- $a dieta s vysokým obsahem tuků $7 D059305
- 650 _2
- $a glukosa $x metabolismus $7 D005947
- 650 12
- $a porucha glukózové tolerance $x metabolismus $7 D018149
- 650 12
- $a inzulinová rezistence $7 D007333
- 650 _2
- $a játra $x metabolismus $7 D008099
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a obezita $x metabolismus $7 D009765
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Strnadová, Veronika $u Biochemistry and molecular biology, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610 Prague, Czech Republic
- 700 1_
- $a Železná, Blanka $u Biochemistry and molecular biology, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610 Prague, Czech Republic
- 700 1_
- $a Kuneš, Jaroslav $u Biochemistry and molecular biology, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610 Prague, Czech Republic $u Experimental hypertension, Institute of Physiology of the Czech Academy of Sciences, 14200 Prague, Czech Republic
- 700 1_
- $a Kašpárek, Petr $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec 25250, Czech Republic
- 700 1_
- $a Maletínská, Lenka $u Biochemistry and molecular biology, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610 Prague, Czech Republic $1 https://orcid.org/0000000342998983
- 773 0_
- $w MED00009494 $t Clinical science (1979) $x 1470-8736 $g Roč. 137, č. 10 (2023), s. 847-862
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37191311 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213094525 $b ABA008
- 999 __
- $a ok $b bmc $g 2049743 $s 1210991
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 137 $c 10 $d 847-862 $e 2023May31 $i 1470-8736 $m Clinical science (1979) $n Clin Sci (Lond) $x MED00009494
- LZP __
- $a Pubmed-20240109